Wisconsin Alumni Research Foundation

Wisconsin Alumni Research Foundation
Name	Wisconsin Alumni Research Foundation
Formation	1925
Type	Research foundation
Headquarters	Madison, Wisconsin
Founder	Harry Steenbock, University of Wisconsin–Madison alumni
Leader title	President (historical)

Wisconsin Alumni Research Foundation is a nonprofit organization associated with University of Wisconsin–Madison that manages intellectual property arising from university research. Founded in 1925, it holds patents, licenses inventions, and distributes income to support research, faculty, and students. WARF has influenced technology transfer practices at institutions such as Stanford University, Massachusetts Institute of Technology, and University of California, Berkeley while engaging with companies including Genentech, 3M, and Medtronic.

History

The foundation emerged after scientist Harry Steenbock developed a method to increase vitamin D in food and sought protection against commercial exploitation by firms such as Quaker Oats and Kahler Corporation. Early governance involved University of Wisconsin–Madison administrators and alumni networks including figures from Madison, Wisconsin and the Wisconsin State Legislature. WARF’s model paralleled later efforts at Columbia University, Yale University, and Harvard University to manage inventions like those from Selman Waksman, John Vincent Atanasoff, and Vannevar Bush. Over decades the foundation navigated patent law developments including decisions by the United States Court of Appeals for the Federal Circuit and policies influenced by the Bayh–Dole Act era debates, intersecting with presidents and provosts from institutions such as Princeton University and Cornell University.

Mission and Activities

WARF’s mission centers on protecting inventions from researchers at University of Wisconsin–Madison and deploying revenue to support scholars, graduate programs, and facilities. Activities include patent prosecution in offices like United States Patent and Trademark Office and international filings through entities such as the European Patent Office and World Intellectual Property Organization. The foundation negotiates licenses with corporations including Johnson & Johnson, Pfizer, Abbott Laboratories, and startups spun out by incubators like Zeroc to One-style ventures and regional accelerators in Madison, Wisconsin. WARF also funds scholarships, endowed chairs, and capital projects that benefit units such as the School of Medicine and Public Health, College of Engineering, and Department of Biochemistry.

Organizational Structure and Governance

The foundation is governed by a board of trustees composed of alumni, legal counsel, and former university officials with ties to organizations such as American Association of University Professors and legal firms like Quarles & Brady. Executive leadership has included presidents and general counsels who liaise with chancellors of University of Wisconsin–Madison and deans from schools like Nelson Institute for Environmental Studies. Financial oversight involves audit committees, investment managers, and advisors that interact with firms such as Fidelity Investments and BlackRock. WARF’s governance structure reflects precedents set by foundations at Duke University, Northwestern University, and University of Pennsylvania.

Patent Management and Licensing

WARF manages patent portfolios arising from research by faculty including Nobel laureates and investigators with ties to laboratories like Wisconsin Institute for Discovery and centers such as Morgridge Institute for Research. It prosecutes patents in subject areas exemplified by inventions from researchers comparable to Har Gobind Khorana, Paul Berg, and Roger Kornberg in biomedicine, as well as engineering innovations reminiscent of work at Bell Labs and MIT Lincoln Laboratory. Licensing agreements have been executed with multinational corporations including Roche, Bristol-Myers Squibb, and Siemens, and have enabled the creation of spinouts akin to Illumina and clinical partners such as Mayo Clinic and Cleveland Clinic. WARF’s licensing practices have been the subject of discussions in venues like the Federal Trade Commission and academic analyses from scholars at Harvard Business School and Stanford Graduate School of Business.

Funding and Financial Impact

Royalty streams from landmark patents—starting with vitamin D fortification—have produced endowments and unrestricted funds that support capital projects, research awards, and faculty salaries at University of Wisconsin–Madison. Investment of proceeds in portfolios managed by institutional investors has enabled grants to units including the Wisconsin Alumni Research Foundation-supported programs, fellowships named after donors from Milwaukee and Chicago, and infrastructure projects such as laboratory buildings and libraries. WARF’s financial influence is comparable to technology transfer offices at University of Michigan, University of Washington, and Johns Hopkins University in shaping regional innovation ecosystems and attracting companies to the Madison, Wisconsin area.

Partnerships and Notable Contributions

The foundation has partnered with technology companies, hospitals, and research institutes to translate discoveries from laboratories like Biochemistry Department, UW–Madison into products. Notable collaborations have facilitated commercialization paths similar to those of Genzyme, Vertex Pharmaceuticals, and Amgen while supporting public health initiatives tied to vaccines and diagnostics akin to efforts by Centers for Disease Control and Prevention and World Health Organization. WARF-supported inventions contributed to agricultural, medical, and industrial applications related to work at Archer Daniels Midland, Cargill, and collaborations with federal labs including National Institutes of Health and Argonne National Laboratory.

Category:University of Wisconsin–Madison Category:Intellectual property organizations